Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

American Journal of Clinical Pathology

Volumn 140, Issue 5, 2013, Pages 736-746

  Tubbs, Raymond R ^a   Wang, Hongwei ^b   Wang, Zhen ^a   Minca, Eugen C ^a   Portier, Bryce P ^a   Gruver, Aaron M ^a   Lanigan, Christopher ^a   Luo, Yuling ^b   Cook, James R ^a   Ma, Xiao Jun ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b Advanced Cell Diagnostics   (United States)

Author keywords

B cell clonality; B cell lymphoma; BRISH; CISH; In situ hybridization; RNAscope

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MESSENGER RNA;

ARTICLE; BRIGHT FIELD IN SITU HYBRIDIZATION; CANCER CELL CULTURE; FEASIBILITY STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LIGHT CHAIN; LIGHT CHAIN RESTRICTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

B-CELL CLONALITY; B-CELL LYMPHOMA; BRISH; CISH; IN SITU HYBRIDIZATION; RNASCOPE;

B-LYMPHOCYTES; CELL LINE, TUMOR; CLONE CELLS; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISORDERS; RNA, MESSENGER;

EID: 84886310101     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPJTWK07FSABRJ     Document Type: Article

References (31)

1. Korsmeyer SJ, Hieter PA, Ravetch JV, et al. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981;78:7096-7100.
2. Cook JR. Molecular hematopathology. In: Tubbs RR, Stoler M, eds. Cell and Tissue Based Molecular Pathology. Philadelphia, PA: Churchill Livingstone Elsevier; 2008:305-324.
3. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111:3941-3967.
4. Demurtas A, Accinelli G, Pacchioni D, et al. Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: a series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol. 2010;18:311-322.
5. Loi TH, Campain A, Bryant A, et al. Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling. BMC Med Genomics. 2011;4:27.
6. Beck RC, Tubbs RR, Hussein M, et al. Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphoma. Diagn Mol Pathol. 2003;12:14-20.
7. Magro C, Crowson AN, Porcu P, et al. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application. J Cutan Pathol. 2003;30:504-511.
8. Segal GH, Shick HE, Tubbs RR, et al. In situ hybridization analysis of lymphoproliferative disorders: assessment of clonality by immunoglobulin light chain messenger RNA expression. Diagn Mol Pathol. 1994;3:170-177.
9. Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874-1882.
10. Bordeaux JM, Cheng H, Welsh AW, et al. Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. PLoS One. 2012;7:e36559.
11. Kim MA, Jung JE, Lee HE, et al. In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry. Hum Pathol. 2013;44:487-494.
12. Schache AG, Liloglou T, Risk JM, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer. 2013;108:1332-1339.
13. Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343-1350.
14. Wang F, Flanagan J, Su N, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14:22-29.
15. Wang Z, Portier BP, Gruver AM, et al. Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma. J Mol Diagn. 2013;15:210-219.
16. Taylor CR. The WHO classification of lymphomas: costeffective immunohistochemistry using a deductive reasoning "decision tree" approach: part II: the decision tree approach: diffuse patterns of proliferation in lymph nodes. Appl Immunohistochem Mol Morphol. 2009;17:470-482.
17. Taylor CR. IHC and the WHO classification of lymphomas: cost effective immunohistochemistry using a deductive reasoning "decision tree" approach. Appl Immunohistochem Mol Morphol. 2009;17:366-374.
18. Boer A, Tirumalae R, Bresch M, et al. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies. Br J Dermatol. 2008;159:394-402.
19. Hoeve MA, Krol AD, Philippo K, et al. Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. Mol Pathol. 2000;53:194-200.
20. Evans RJ, Hollis GF. Genomic structure of the human Igl1 gene suggests that it may be expressed as an Igl14.1-like protein or as a canonical B cell Igl light chain: implications for Igl gene evolution. J Exp Med. 1991;173:305-311.
21. Shimanuki M, Sonoki T, Hosoi H, et al. Molecular cloning of IGl rearrangements using long-distance inverse PCR (LDIPCR). Eur J Haematol. 2013;90:59-67.
22. Angel CA, Pringle JH, Primrose L, et al. Detection of immunoglobulin heavy chain gene rearrangements in Hodgkin's disease using PCR. J Clin Pathol. 1993;46:940-942.
23. Chute DJ, Cousar JB, Mahadevan MS, et al. Detection of immunoglobulin heavy chain gene rearrangements in classic Hodgkin lymphoma using commercially available BIOMED-2 primers. Diagn Mol Pathol. 2008;17:65-72.
24. Deng F, Lu G, Li G, et al. Hodgkin's disease: immunoglobulin heavy and light chain gene rearrangements revealed in single Hodgkin/Reed-Sternberg cells. Mol Pathol. 1999;52:37-41.
25. Kanzler H, Kuppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495-1505.
26. Kuppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol. 1998;16:471-493.
27. Kuppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A. 1994;91:10962-10966.
28. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed- Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95:1443-1450.
29. Gulley ML. Immunoglobulin and T-cell receptor gene rearrangement. In: Tubbs RR, Stoler MH, eds. Cell and Tissue Based Molecular Pathology. Philadelphia, PA: Churchill Livingstone Elsevier; 2008:127-134.
30. Kroft SH. Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis. Am J Clin Pathol. 2004;121:457-459.
31. Xu D. Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders. Arch Pathol Lab Med. 2006;130:853-856.